Mother Of Mercy Senior Living | |
230 Church Avenue, Box 676, Albany, Minnesota 56307 | |
(320) 845-2195 | |
Name | Mother Of Mercy Senior Living |
---|---|
Location | 230 Church Avenue, Box 676, Albany, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 70 |
Occupancy Rate | 69.86% |
Medicare ID (CCN) | 245339 |
Legal Business Name | Mother Of Mercy |
Ownership Type | Non Profit - Corporation |
NPI Number | 1104899939 |
Organization Name | MOTHER OF MERCY |
Doing Business As | MOTHER OF MERCY SENIOR LIVING |
Address | 230 Church Avenue, Albany, MN 56307 |
Phone Number | 320-845-2195 |
News Archive
While root canals are effective in saving a tooth that has become infected or decayed, this age-old procedure may cause teeth to become brittle and susceptible to fracture over time. Now researchers at OHSU in Portland, Oregon, have developed a process by which they can engineer new blood vessels in teeth, creating better long-term outcomes for patients and clinicians.
A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
Health and Human Services Secretary Kathleen Sebelius' comments were made during a White House-sponsored town hall meeting for senior citizens. Meanwhile, new figures from the Centers for Medicare & Medicaid Services indicate that some Medicare beneficiaries are not taking advantage of some of the new benefits.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
While root canals are effective in saving a tooth that has become infected or decayed, this age-old procedure may cause teeth to become brittle and susceptible to fracture over time. Now researchers at OHSU in Portland, Oregon, have developed a process by which they can engineer new blood vessels in teeth, creating better long-term outcomes for patients and clinicians.
A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
Health and Human Services Secretary Kathleen Sebelius' comments were made during a White House-sponsored town hall meeting for senior citizens. Meanwhile, new figures from the Centers for Medicare & Medicaid Services indicate that some Medicare beneficiaries are not taking advantage of some of the new benefits.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 12.75 | 14.46 |
Percentage of long-stay residents who lose too much weight | 1.3 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.87 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.54 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.67 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.99 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 26.37 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.45 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 27.22 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.74 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 1.2 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.81 | 95.98 |
Percentage of short-stay residents who made improvements in function | 89.39 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.18 | 82.93 |
News Archive
While root canals are effective in saving a tooth that has become infected or decayed, this age-old procedure may cause teeth to become brittle and susceptible to fracture over time. Now researchers at OHSU in Portland, Oregon, have developed a process by which they can engineer new blood vessels in teeth, creating better long-term outcomes for patients and clinicians.
A team led by scientists at The Scripps Research Institute (TSRI) has identified a family of tiny RNA molecules that work as powerful regulators of the immune response in mammals. Mice who lack these RNA molecules lose their normal infection-fighting ability, whereas mice that overproduce them develop a fatal autoimmune syndrome.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
Health and Human Services Secretary Kathleen Sebelius' comments were made during a White House-sponsored town hall meeting for senior citizens. Meanwhile, new figures from the Centers for Medicare & Medicaid Services indicate that some Medicare beneficiaries are not taking advantage of some of the new benefits.
› Verified 8 days ago
Mother Of Mercy Senior Living Location: 230 Church Avenue, Box 676, Albany, Minnesota 56307 Phone: (320) 845-2195 |